Adcock Ingram Holdings Ltd

AIPJ.J

$2.88

Closing

▲0.51%

1D

▼-8.49%

YTD

Market cap

$488.63M

52 week high

$3.22

52 week low

$2.60

Volume

79,379

Check if the stock is halal

Unlock Industry-grade Shariah Compliance for global stocks. See results from 5 major Shariah standards: AAOIFI, S&P, DJIM, FTSE and MSCI.

We provide unparalleled value and service.
Screened by AAOIFI Certified Shariah Advisor & Auditor.

Get started from just $3.99/month

Market cap

$488.63M

Analysts' Rating

HOLD

Price Target (Mean)

0.00

Total Analysts

0

P/E

10.02

Operating Margin

0.00%

Beta

0.42

Revenue Growth (Annual)

-

52 week high

$3.22

52 week low

$2.60

Div. Yield

4.55%

EPS Annual Growth

0.00

Note on Purification and Zakat

  • Purification and Zakat (for long-term investing) calculations are in USD per share and based on AAOIFI methodology. AAOIFI requires purification every financial period (e.g. quarterly). 
  • If you follow S&P Shariah’s Dividend-only purification, then remove the impure income % from the dividends you receive. No purification required for non-dividend paying stocks, according to S&P Shariah.
  • For Zakat, if you did not invest in a company from a long term perspective, then consider the shares as trading goods and give 2.5% of the total value if a year has passed on them. 

Company Profile

Adcock Ingram Holdings Limited is a South Africa-based healthcare company. The Company is engaged in supplying specialty, branded and generic pharmaceutical products, hospital products, and fast-moving consumer goods (FMCG). Its segments include Consumer, Over the Counter (OTC), Prescription, Hospital, and Other. The Consumer segment is engaged mainly in the FMCG retail space. Its OTC segment focuses on brands sold predominantly in pharmacies. Its Prescription segment markets products prescribed by medical practitioners, and specialized instruments and surgical products. Its Hospital segment supplies hospital and critical care products, including intravenous solutions, blood collection products and renal dialysis systems. Its Other segment includes shared services and other support services, including regulatory services in India, as well as the investment in the Indian joint venture and cash and bank overdraft balances which are managed on a central basis in Southern Africa.